First-generation copper peptides, second-generation SRCP formulations, various ratios of peptide to copper, synthetic versus naturally occurring variants, each designed for specific applications that most guides fail to distinguish
With proper aseptic training and follow-up, select patients may self-inject subcutaneously, enhancing adherence and convenience
Key Details Molecular Formula: CHNOS Molecular Weight: 1815 g/mol CAS Number: 386264-39-7 Potential Research Applications Metabolic Investigations AOD9604 is employed in laboratory settings to explore how C-terminal growth hormone fragments might affect fatty acid mobilization and the overall lipid profile in vitro and in vivo [2]
Safety, side effects, and contraindications AHK-Cu demonstrates a favorable safety profile in available research and clinical experience
Can refrigerate after opening, especially in very hot climates